Robert P Smilanich, MD | |
1055 N 300 W, Suite 205, Provo, UT 84604-3374 | |
(801) 374-9100 | |
(801) 374-9117 |
Full Name | Robert P Smilanich |
---|---|
Gender | Male |
Speciality | Vascular Surgery |
Experience | 34 Years |
Location | 1055 N 300 W, Provo, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730187600 | NPI | - | NPPES |
638375 | Other | UT | DMBA |
870656925SM1 | Other | UT | EMIA |
30893841201001 | Other | UT | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0129X | Surgery - Vascular Surgery | 3089384-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Utah Valley Hospital | Provo, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Medicare payments for outpatient prescription medications increased by more than $38 billion when comparing 2005 and 2006 data, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The United States Food and Drugs Administration (FDA) have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been concerning patients and families particularly of the children with leukemia. But there are currently 283 separate prescription drugs in short supply or unavailable nationwide, and regulators and manufacturers say shortages are a long-term problem that will continue to scare patients and doctors.
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, announced today that positive Phase 1 clinical data for BIND-014, the company's lead drug candidate, were presented today in an oral presentation at the American Association for Cancer Research 2013 Annual Meeting.
The study looked at 24 lean women and 24 overweight and obese women, all of whom underwent several behavioral assessments to determine differences in each person's motivation level, their perspective on time and how much they sought out fun and responded to rewards.
› Verified 4 days ago
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Medicare payments for outpatient prescription medications increased by more than $38 billion when comparing 2005 and 2006 data, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The United States Food and Drugs Administration (FDA) have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been concerning patients and families particularly of the children with leukemia. But there are currently 283 separate prescription drugs in short supply or unavailable nationwide, and regulators and manufacturers say shortages are a long-term problem that will continue to scare patients and doctors.
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, announced today that positive Phase 1 clinical data for BIND-014, the company's lead drug candidate, were presented today in an oral presentation at the American Association for Cancer Research 2013 Annual Meeting.
The study looked at 24 lean women and 24 overweight and obese women, all of whom underwent several behavioral assessments to determine differences in each person's motivation level, their perspective on time and how much they sought out fun and responded to rewards.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Robert P Smilanich, MD 1055 N 300 W, Suite 205, Provo, UT 84604-3374 Ph: (801) 374-9100 | Robert P Smilanich, MD 1055 N 300 W, Suite 205, Provo, UT 84604-3374 Ph: (801) 374-9100 |
News Archive
Medicare payments for outpatient prescription medications increased by more than $38 billion when comparing 2005 and 2006 data, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The United States Food and Drugs Administration (FDA) have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been concerning patients and families particularly of the children with leukemia. But there are currently 283 separate prescription drugs in short supply or unavailable nationwide, and regulators and manufacturers say shortages are a long-term problem that will continue to scare patients and doctors.
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, announced today that positive Phase 1 clinical data for BIND-014, the company's lead drug candidate, were presented today in an oral presentation at the American Association for Cancer Research 2013 Annual Meeting.
The study looked at 24 lean women and 24 overweight and obese women, all of whom underwent several behavioral assessments to determine differences in each person's motivation level, their perspective on time and how much they sought out fun and responded to rewards.
› Verified 4 days ago
Dr. John Emil Wennergren, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3550 N University Ave Ste 250, Provo, UT 84604 Phone: 801-374-9625 Fax: 801-374-9625 | |
Brian Gill, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3550 N. University Ave. #250, Provo, UT 84604 Phone: 801-374-9625 Fax: 801-374-9690 | |
Dr. James M Clayton Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 280 River Park Dr, Ste 240, Provo, UT 84604 Phone: 801-375-4646 Fax: 801-375-1999 | |
James Robert Barrett, MD Surgery Medicare: Medicare Enrolled Practice Location: 3550 N University Ave Ste 250, Provo, UT 84604 Phone: 801-374-9625 Fax: 801-374-9690 | |
Dr. Todd B Engen, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1735 N State St, Provo, UT 84604 Phone: 801-379-2900 Fax: 801-374-6295 | |
Lee M Peterson, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3550 N University Ave, Suite 250, Provo, UT 84604 Phone: 801-374-9625 Fax: 801-374-9690 | |
James Rielly, Surgery Medicare: Accepting Medicare Assignments Practice Location: 395 W Cougar Blvd Ste 503, Provo, UT 84604 Phone: 801-374-9100 Fax: 801-374-9117 |